the first experience in patients ( phase ii studies ) with iohexol ( omnipaque ) - a new non-ionic contrast medium - in intravenous urography ( 34 patients ) , cardioangiography ( 45 patients ) and cerebral angiography ( 38 patents ) is collectively reported .
C0022005
iohexol
C0729203
omnipaque